Michael H. Carrel
Net Worth

Last updated:

What is Michael H. Carrel net worth?

The estimated net worth of Mr. Michael H. Carrel is at least $30,743,497 as of 12 Feb 2021. He owns shares worth $17,920,223 as insider, has earned $6,223,274 from insider trading and has received compensation worth at least $6,600,000 in AtriCure, Inc..

What is the salary of Michael H. Carrel?

Mr. Michael H. Carrel salary is $1,100,000 per year as Chief Executive Officer, Pres & Director in AtriCure, Inc..

How old is Michael H. Carrel?

Mr. Michael H. Carrel is 54 years old, born in 1971.

What stocks does Michael H. Carrel currently own?

As insider, Mr. Michael H. Carrel owns shares in one company:

Company Title Shares Price per share Total value
AtriCure, Inc. (ATRC) Chief Executive Officer, Pres & Director 504,795 $35.5 $17,920,223

What does AtriCure, Inc. do?

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, the company sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Michael H. Carrel insider trading

AtriCure, Inc.

Mr. Michael H. Carrel has made 26 insider trades between 2019-2021, according to the Form 4 filled with the SEC. Most recently he sold 25,000 units of ATRC stock on 12 Feb 2021.

The largest trade he's ever made was exercising 50,249 units of ATRC stock on 18 Dec 2020. As of 12 Feb 2021 he still owns at least 504,795 units of ATRC stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 25,000 N/A N/A
Option
Common Stock 25,000 $21.04 $526,000
Option
Stock Option (Right to Buy) 25,000 $21.04 $526,000
Option
Stock Option (Right to Buy) 25,000 N/A N/A
Sale
Common Stock 25,000 N/A N/A
Option
Common Stock 25,000 $21.04 $526,000
Option
Stock Option (Right to Buy) 25,000 N/A N/A
Option
Common Stock 25,000 N/A N/A
Sale
Common Stock 25,000 $21.04 $526,000
Option
Stock Option (Right to Buy) 25,000 $21.04 $526,000
Sale
Common Stock 25,000 $21.04 $526,000
Option
Common Stock 25,000 N/A N/A
Option
Common Stock 25,000 $21.04 $526,000
Sale
Common Stock 25,000 N/A N/A
Option
Stock Option (Right to Buy) 25,000 $21.04 $526,000
Option
Stock Option (Right to Buy) 25,000 $21.04 $526,000
Sale
Common Stock 25,000 $21.04 $526,000
Option
Common Stock 25,000 N/A N/A
Sale
Common Stock 25,000 N/A N/A
Option
Stock Option (Right to Buy) 25,000 $21.04 $526,000
Option
Common Stock 25,000 N/A N/A
Option
Common Stock 24,953 $58 $1,447,274
Option
Stock Option (Right to buy) 24,953 N/A N/A
Sale
Common Stock 24,953 $58 $1,447,274
Option
Stock Option (Right to Buy) 47 N/A N/A
Sale
Common Stock 47 N/A N/A
Option
Common Stock 47 $21.04 $989
Option
Common Stock 50,000 $57 $2,850,000
Option
Common Stock 50,000 $28.5 $1,425,000
Option
Stock Option (Right to Buy) 50,000 $28.5 $1,425,000
Sale
Common Stock 25,000 $57 $1,425,000
Option
Stock Option (Right to Buy) 50,000 N/A N/A
Sale
Common Stock 24,751 N/A N/A
Option
Common Stock 24,751 $21.04 $520,761
Option
Stock Option (Right to Buy) 24,751 $21.04 $520,761
Sale
Common Stock 50,249 N/A N/A
Option
Common Stock 50,249 N/A N/A
Option
Stock Option (Right to Buy) 50,249 N/A N/A
Option
Common Stock 25,000 $5.91 $147,750
Sale
Common Stock 25,000 N/A N/A
Option
Stock Option (Right to Buy) 25,000 $5.91 $147,750
Option
Stock Option (Right to buy) 25,000 N/A N/A
Sale
Common Stock 25,000 $5.91 $147,750
Option
Stock Option (Right to Buy) 25,000 $5.91 $147,750
Option
Common stock 25,000 $5.91 $147,750
Option
Common Stock 25,000 $5.91 $147,750
Option
Stock Option (Right to buy) 25,000 $5.91 $147,750
Sale
Common Stock 25,000 $5.91 $147,750
Option
Common Stock 25,000 $5.91 $147,750
Sale
Common Stock 25,000 $5.91 $147,750
Option
Stock Option (Right to buy) 25,000 $5.91 $147,750
Option
Common Stock 25,000 $5.91 $147,750
Sale
Common Stock 25,000 $5.91 $147,750
Option
Stock Option (Right to buy) 25,000 $5.91 $147,750
Sale
Common Stock 25,000 $5.91 $147,750
Option
Common Stock 25,000 $5.91 $147,750
Option
Stock Option (Right to buy) 25,000 $5.91 $147,750
Option
Stock Option (Right to Buy) 25,000 $5.91 $147,750
Sale
Common Stock 25,000 $5.91 $147,750
Option
Common Stock 25,000 $5.91 $147,750
Option
Common Stock 25,000 $5.91 $147,750
Option
Stock Option (Right to buy) 25,000 $5.91 $147,750
Sale
Common Stock 25,000 $5.91 $147,750
Sale
Common Stock 25,000 $5.91 $147,750
Option
Common Stock 25,000 $5.91 $147,750
Option
Stock Option (Right to Buy) 25,000 $5.91 $147,750
Option
Stock Option (Right to Buy) 25,000 $5.91 $147,750
Option
Common Stock 25,000 $5.91 $147,750
Sale
Common Stock 25,000 $5.91 $147,750
Option
Common Stock 25,000 $5.91 $147,750
Sale
Common Stock 25,000 $5.91 $147,750
Option
Stock Option (Right to Buy) 25,000 $5.91 $147,750
Option
Common Stock 23,546 $5.91 $139,157
Sale
Common Stock 23,546 $5.91 $139,157
Option
Stock Option (Right to Buy) 23,546 $5.91 $139,157
Sale
Common Stock 1,454 $5.91 $8,593
Option
Stock Option (Right to Buy) 1,454 $5.91 $8,593
Option
Common Stock 1,454 $5.91 $8,593
Option
Common Stock 25,000 $5.91 $147,750
Sale
Common Stock 25,000 $5.91 $147,750
Option
Stock Option (Right to Buy) 25,000 $5.91 $147,750

AtriCure key executives

AtriCure, Inc. executives and other stock owners filed with the SEC: